BioReference makes acquisition, establishes West Coast presence

BioReference Laboratories (BRLI +2%) acquires most of Hunter Laboratories' assets, giving BRLI a West Cost presence and Medi-Cal in-network status.

"Having a local base for operations can provide significant operational and logistical synergies," CEO Marc Grodman notes. (PR)

Shares of Neogenomics (NEO -7.8%), a notable peer, are off sharply on the session.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs